In the latest trading session, 33.27 million Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) shares changed hands as the company’s beta touched 1.61. With the company’s most recent per share price at $2.39 changing hands around $0.37 or 18.86% at last look, the market valuation stands at $1.39M. BDRX’s current price is a discount, trading about -2996.23% off its 52-week high of $74.00. The share price had its 52-week low at $1.84, which suggests the last value was 23.01% up since then. When we look at Biodexa Pharmaceuticals Plc ADR’s average trading volume, we note the 10-day average is 2.8 million shares, with the 3-month average coming to 914.37K.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) trade information

Instantly BDRX is in green as seen in intraday trades today. With action 22.19%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -40.86%, with the 5-day performance at 22.19% in the green. However, in the 30-day time frame, Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX) is -44.56% down. Looking at the short shares, we see there were 36118.0 shares sold at short interest cover period of 0.03 days.

Biodexa Pharmaceuticals Plc ADR (BDRX) estimates and forecasts

Year-over-year growth is forecast to reach -100.00% down from the last financial year. Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 86.34%. The 2025 estimates are for Biodexa Pharmaceuticals Plc ADR earnings to increase by 99.87%, but the outlook for the next 5-year period is at 89.98% per year.

Biodexa Pharmaceuticals Plc ADR (NASDAQ:BDRX)’s Major holders

If we look at who the major shareholders are, we find that insiders hold 8.82% of Biodexa Pharmaceuticals Plc ADR shares while 29.86% of the shares are in the hands of institutional holders. The share float percentage for the stock currently stands at 32.75%. With 78.0 shares estimated at $188.0 under it, the former controlled 0.00% of total outstanding shares.